ITGAV and Cirrhosis: Additionally, ligand–receptor pairs such as SPP1–ITGAV, VTN–ITGAV, and HLA-related interactions were more active in cirrhosis, suggesting their potential roles in macrophage polarization, immune evasion, and tumor cell adhesion or migration.